Synthesis and anti-HIV activity of some novel arylphosphate and H-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine and 2',3'-didehydro-2',3'-dideoxythymidine

Antiviral Research

Volumn 42, Issue 3, 1999, Pages

  Cardona, Valérie M F ^a   Ayi, Ayicoué I ^a   Aubertin, Anne Marie ^b   Guedj, Roger ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b INSERM   (France)

Author keywords

AZT d4T Phosphate derivatives; HIV chemotherapy; Nucleoside H phosphonates; Nucleotide; Prodrugs

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NUCLEOSIDE ANALOG; NUCLEOTIDE; STAVUDINE; THYMIDINE DERIVATIVE; ZIDOVUDINE DERIVATIVE;

ANTIVIRAL ACTIVITY; CONFERENCE PAPER; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTI-HIV AGENTS; CELL LINE; DRUG EVALUATION, PRECLINICAL; HIV-1; HUMANS; PHOSPHORIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; ZIDOVUDINE;

EID: 0344242138     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00021-2     Document Type: Conference Paper

References (20)

1. Balzarini J., Herdewijn P., De Clercq E. Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J. Biol. Chem. 264:1989;6127-6133.
2. Balzarini J., Egberink H., Hartmann K., Cahard D., Vahlenkamp T., Thormar H., De Clercq E., McGuigan C. Antiretrovirus specificity and intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine (stavudine) and its 5′-monophosphate triester prodrug So324. Mol. Pharmacol. 50:1996;1207-1213.
3. Cardona, V.M.F., Ayi, A.I., Aubertin, A.-M., Guedj, R., 1998a. New compounds, nucleotide analogues, their methods of preparation and their applications. French Patent 98/09140.
4. Cardona, V.M.F., Ayi, A.I., Aubertin, A.M., Guedj, R., 1998b. In: Program and Abstracts of the Eleventh International Conference on Antiviral Research. San Diego, CA, April 5-10, 37/3, A52, [Abstract 40].
5. Czernecki S., Valéry J.-M., An efficient synthesis of 3′-azido-3′-deoxythymidine (AZT), Synthesis 1991:239-240.
6. De Clercq E. HIV inhibitors targeted at the reverse transcriptase. AIDS Res. Hum. Retroviruses. 8:1992;119-134.
7. Girardet J.-L., Périgaud C., Aubertin A.-M., Gosselin G., Kirn A., Imbach J.-L. Increase of the anti-HIV activity of d4T in human T-cell culture by the use of the SATE pronucleotide approach. Bioorg. Med. Chem. Lett. 5:1995;2981-2984.
8. Hitchcock M.J.M. Review: Antiviral Portrait Series, Number 1: 2′,3′-didehydro-2′,3′-dideoxythymidine (d4T), an anti-HIV agent. Antiviral Chem. Chemother. 2:1991;125-132.
9. Ho H.-T., Hitchcock M.J.M. Cellular pharmacology of 2′,3′-dideoxy-2′,3′-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob. Agents Chemother. 33:1989;844-849.
10. Horwitz J.P., Chua J., Da Rooge M.A., Noel M., Klundt I.L. Nucleosides. IX. The formation of 2′,3′-unsaturated pyrimidine nucleosides via a novel β-elimination reaction. J. Org. Chem. 31:1966;205-211.
11. Horwitz J.P., Chua J. 1-(2,3-dideoxy-β-d-glycero-pent-2-enofuranosyl)thymine. Synth. Proc. Nucl. Acid. 1:1968;344-346.
12. Krayevsky A.A., Tarussova N.B., Zhu Q.-Y., Vidal P., Chou T.-C., Baron P., Polsky B., Jiang X.-J., Matulic-Adamic J., Rosenberg I., Watanabe K.A. 5′-Hydrogenphosphonates and 5′-methylphosphonates of sugar modified pyrimidine nucleosides as potential anti-HIV-1 agents. Nucleosides Nucleotides. 11:1992;177-196.
13. Lefebvre I., Perigaud C., Pompon A., Aubertin A.-M., Girardet J.-L., Kirn A., Gosselin G., Imbach J.-L. Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3′-azido-2′,3′-dideoxythymidine 5′-monophosphate. J. Med. Chem. 38:1995;3941-3950.
14. Mansuri M.M., Starrett Jr J.E., Ghazzouli I., Hitchcock M.J.M., Sterzycki R.Z., Brankovan V., Lin T.-S., August E.M., Prusoff W.H., Sommadossi J.-P. 1-(2,3-dideoxy-(-d-glycero-pent-2-enofuranosyl)thymine a highly potent and selective anti-HIV agent. J. Med. Chem. 32:1989;461-466.
15. McGuigan C., Nicholls S.R., O'Connor T.J., Kinchington D. Synthesis of some novel dialkyl phosphate derivatives of 3′-modified nucleosides as potential anti-AIDS drugs. Antiviral Chem. Chemother. 1:1990;25-33.
16. McGuigan C., Bellevergue P., Jones B.C.N.M., Mahmood N., Hay A.J., Petrik J., Karpas A. Alkyl hydrogen phosphonate derivatives of the anti-HIV agent AZT may be less toxic than the parent nucleoside analogue. Antiviral Chem. Chemother. 5:1994;271-277.
17. McGuigan C., Davies M., Pathirana R., Mahmood N., Hay A.J. Synthesis and anti-HIV activity of some novel diaryl phosphate derivatives of AZT. Antiviral Res. 24:1994;69-77.
18. Meier, C., Habel, L.W., Balzarini, J., De Clercq, E., 1995. 5′,5′-Di-O-nucleosyl-O′-benzylphosphotriesters as potential prodrugs of 3′-azido-2′,3′-dideoxythymidine-5′-monophosphate. Liebigs Ann. 2203-2208.
19. Meier C., Lorey M., De Clercq E., Balzarini J. Cyclic saligenyl phosphotriesters of 2′,3′-didehydro-2′,3′-dideoxythymidine (d4T)-A new pro-nucleotide approach. Bioorg. Med. Chem. Lett. 7:1997;99-104.
20. Sommadossi J.-P. Nucleoside analogs: similarities and differences. J. Infect. Dis. 16(suppl. 1):1993;7-15.